Insulet Corporation Interest Expense 2011-2026 | PODD

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Insulet Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
14.3 M	-5.5 M	36.2 M	36 M	61.7 M	48.1 M	34.6 M	28.9 M	21.2 M	14.4 M	12.7 M	-1.22 M	1.43 M	-	-14.6 M	-22.5 M	-13 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
61.7 M	-22.5 M	15.8 M

Quarterly Interest Expense Insulet Corporation

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
700 K	12.1 M	1.3 M	-2.3 M	-	-3.4 M	-1.8 M	-700 K	-	700 K	-200 K	9.4 M	-	9.2 M	9.1 M	9 M	-	16.4 M	16.6 M	13.6 M	-	11.9 M	11.8 M	11.6 M	-	9.4 M	7.7 M	6.6 M	-	6.85 M	7.29 M	1.68 M	-	556 K	488 K	434 K	-	211 K	129 K	170 K	-	21 K	28 K	27 K	-	-677 K	300 K	300 K	-	100 K	-	-	-	-3.92 M	-3.89 M	-3.84 M	-	-3.79 M	-4.51 M	-2.58 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
16.6 M	-4.51 M	3.27 M

Interest Expense of other stocks in the Medical devices industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Cutera CUTR	-244 K	-	-10.19 %	$ 1.99 M	USA
EDAP TMS S.A. EDAP	232 K	-	-	$ 162 M	France
Avinger AVGR	1.72 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	624 K	-	-	$ 3.31 B	USA
Eargo EAR	549 K	-	-	$ 10.2 M	USA
Allied Healthcare Products AHPI	191 K	-	3.58 %	$ 2.21 M	USA
ClearPoint Neuro CLPT	-146 K	$ 13.52	0.6 %	$ 383 M	USA
Apollo Endosurgery APEN	4.67 M	-	-	$ 475 M	USA
Alphatec Holdings ATEC	45.9 M	$ 8.29	0.12 %	$ 1.24 B	USA
Aziyo Biologics AZYO	-2.76 M	-	1.37 %	$ 20.5 M	USA
BioSig Technologies BSGM	1.6 M	-	37.08 %	$ 85.7 M	USA
BIOLASE BIOL	-1 K	-	-13.19 %	$ 166 K	USA
Conformis CFMS	2.02 M	-	-	$ 16.4 M	USA
Cardiovascular Systems CSII	1.63 M	-	0.15 %	$ 844 M	USA
Helius Medical Technologies HSDT	46.9 K	$ 1.75	13.64 %	$ 38.6 M	USA
LivaNova PLC LIVN	664 K	$ 79.7	0.39 %	$ 4.35 B	Britain
OrthoPediatrics Corp. KIDS	6.05 M	$ 18.15	1.85 %	$ 426 M	USA
Pulmonx Corporation LUNG	790 K	$ 1.28	-6.57 %	$ 52.1 M	USA
Delcath Systems DCTH	-70 K	$ 11.79	0.6 %	$ 422 M	USA
Neovasc NVCN	133 K	-	-	$ 111 M	Canada
LENSAR LNSR	636 K	$ 5.72	-1.72 %	$ 68.4 M	USA
Dynatronics Corporation DYNT	410 K	-	14.99 %	$ 929 K	USA
Orthofix Medical OFIX	8.11 M	$ 9.2	-1.18 %	$ 364 M	Curacao
Electromed ELMD	455 K	$ 37.44	-0.5 %	$ 317 M	USA
MiMedx Group MDXG	-558 K	$ 3.68	2.22 %	$ 544 M	USA
Profound Medical Corp. PROF	146 K	$ 6.71	1.28 %	$ 203 M	Canada
Butterfly Network BFLY	2.77 M	$ 5.63	1.62 %	$ 1.39 B	USA
Second Sight Medical Products EYES	947 K	-	-0.97 %	$ 54.4 M	USA
Myomo MYO	-668 K	$ 1.35	16.38 %	$ 56.5 M	USA
Globus Medical GMED	3.41 M	$ 77.32	-3.82 %	$ 10.5 B	USA
CONMED Corporation CNMD	31.1 M	$ 34.16	-1.75 %	$ 1.06 B	USA
Inspire Medical Systems INSP	-2.66 M	$ 41.13	-3.68 %	$ 1.21 B	USA
Integer Holdings Corporation ITGR	-53.2 M	$ 90.85	-0.14 %	$ 3.16 B	USA
Invacare Corporation IVC	28.5 M	-	-	$ 24.7 M	USA
Edwards Lifesciences Corporation EW	7.2 M	$ 86.28	1.37 %	$ 50.5 B	USA
Sintx Technologies SINT	31 K	$ 2.21	0.91 %	$ 6.13 M	USA